ICAM1 and hepatocellular carcinoma: Targeting the Notch1-YY1-ICAM1 Signaling Axis Enhances the Efficacy of Immunotherapy in HCC by Activating CD8&lt;sup&gt;+&lt;/sup&gt; T-Cell-Driven Cancer Cell Pyroptosis.